- Home
- RDN vs BIRK Comparison
RDN vs BIRK Comparison
Compare RDN & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | RDN | BIRK |
|---|---|---|
| Founded | 1977 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.6B |
| IPO Year | 2008 | 2023 |
Fundamental Metrics
Financial Performance| Metric | RDN | BIRK |
|---|---|---|
| Price | $34.88 | $30.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | $40.67 | ★ $61.43 |
| AVG Volume (30 Days) | 903.3K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.73% | N/A |
| EPS Growth | ★ 5.61 | N/A |
| EPS | ★ 1.74 | N/A |
| Revenue | ★ $1,197,084,000.00 | N/A |
| Revenue This Year | N/A | $13.71 |
| Revenue Next Year | $2.66 | $14.30 |
| P/E Ratio | $20.00 | ★ $17.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $31.50 | $29.93 |
| 52 Week High | $41.05 | $50.73 |
Technical Indicators
Market Signals| Indicator | RDN | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 35.65 | 33.34 |
| Support Level | $31.87 | N/A |
| Resistance Level | $37.34 | $37.29 |
| Average True Range (ATR) | 0.68 | 1.08 |
| MACD | -0.12 | -0.04 |
| Stochastic Oscillator | 22.87 | 12.04 |
Price Performance
Historical ComparisonAbout RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one reportable segment, Mortgage Insurance, which primarily derives its revenue by providing private mortgage insurance on residential first-lien mortgage loans to mortgage lending institutions and mortgage credit investors.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.